Cargando…

Tuberculous Spondylitis of the Craniovertebral Junction

Craniovertebral junction tuberculosis is rare, accounting for 0.3 to 1% of all tuberculous spondylitis cases. MR imaging is the modality of choice to detect bone involvement, abscess formation and subligamentous spreading of the pus, to differentiate from other lesions affecting the craniovertebral...

Descripción completa

Detalles Bibliográficos
Autores principales: Megaloikonomos, Panayiotis D., Igoumenou, Vasilios, Antoniadou, Thekla, Mavrogenis, Andreas F., Soultanis, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423568/
https://www.ncbi.nlm.nih.gov/pubmed/28529850
http://dx.doi.org/10.7150/jbji.15884
_version_ 1783234969383993344
author Megaloikonomos, Panayiotis D.
Igoumenou, Vasilios
Antoniadou, Thekla
Mavrogenis, Andreas F.
Soultanis, Konstantinos
author_facet Megaloikonomos, Panayiotis D.
Igoumenou, Vasilios
Antoniadou, Thekla
Mavrogenis, Andreas F.
Soultanis, Konstantinos
author_sort Megaloikonomos, Panayiotis D.
collection PubMed
description Craniovertebral junction tuberculosis is rare, accounting for 0.3 to 1% of all tuberculous spondylitis cases. MR imaging is the modality of choice to detect bone involvement, abscess formation and subligamentous spreading of the pus, to differentiate from other lesions affecting the craniovertebral junction, and to determine the efficacy of treatment. Given the fact that surgical treatment of patients with craniovertebral junction tuberculosis has been associated with a high mortality rate ranging up to 10% and recurrence rate ranging up to 20%, conservative is the standard of treatment for most patients. This article presents a patient with craniovertebral junction Mycobacterium tuberculosis infection diagnosed with CT-guided biopsy. A halo vest was applied and antituberculous treatment with rifampicin, isoniazid and ethambutol was initiated. At 6-month follow-up, the patient was asymptomatic; CT of the cervical spine showed healing of the bony lesions. The halo vest was removed and physical therapy was recommended. Antituberculous treatment was continued for a total of 18 months, without any evidence of infection recurrence
format Online
Article
Text
id pubmed-5423568
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-54235682017-05-19 Tuberculous Spondylitis of the Craniovertebral Junction Megaloikonomos, Panayiotis D. Igoumenou, Vasilios Antoniadou, Thekla Mavrogenis, Andreas F. Soultanis, Konstantinos J Bone Jt Infect Short Research Communication Craniovertebral junction tuberculosis is rare, accounting for 0.3 to 1% of all tuberculous spondylitis cases. MR imaging is the modality of choice to detect bone involvement, abscess formation and subligamentous spreading of the pus, to differentiate from other lesions affecting the craniovertebral junction, and to determine the efficacy of treatment. Given the fact that surgical treatment of patients with craniovertebral junction tuberculosis has been associated with a high mortality rate ranging up to 10% and recurrence rate ranging up to 20%, conservative is the standard of treatment for most patients. This article presents a patient with craniovertebral junction Mycobacterium tuberculosis infection diagnosed with CT-guided biopsy. A halo vest was applied and antituberculous treatment with rifampicin, isoniazid and ethambutol was initiated. At 6-month follow-up, the patient was asymptomatic; CT of the cervical spine showed healing of the bony lesions. The halo vest was removed and physical therapy was recommended. Antituberculous treatment was continued for a total of 18 months, without any evidence of infection recurrence Ivyspring International Publisher 2016-07-14 /pmc/articles/PMC5423568/ /pubmed/28529850 http://dx.doi.org/10.7150/jbji.15884 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Short Research Communication
Megaloikonomos, Panayiotis D.
Igoumenou, Vasilios
Antoniadou, Thekla
Mavrogenis, Andreas F.
Soultanis, Konstantinos
Tuberculous Spondylitis of the Craniovertebral Junction
title Tuberculous Spondylitis of the Craniovertebral Junction
title_full Tuberculous Spondylitis of the Craniovertebral Junction
title_fullStr Tuberculous Spondylitis of the Craniovertebral Junction
title_full_unstemmed Tuberculous Spondylitis of the Craniovertebral Junction
title_short Tuberculous Spondylitis of the Craniovertebral Junction
title_sort tuberculous spondylitis of the craniovertebral junction
topic Short Research Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423568/
https://www.ncbi.nlm.nih.gov/pubmed/28529850
http://dx.doi.org/10.7150/jbji.15884
work_keys_str_mv AT megaloikonomospanayiotisd tuberculousspondylitisofthecraniovertebraljunction
AT igoumenouvasilios tuberculousspondylitisofthecraniovertebraljunction
AT antoniadouthekla tuberculousspondylitisofthecraniovertebraljunction
AT mavrogenisandreasf tuberculousspondylitisofthecraniovertebraljunction
AT soultaniskonstantinos tuberculousspondylitisofthecraniovertebraljunction